Nonsmokers | Smokers | |||||
Normal lung function | COPD | |||||
PBM | AM | PBM | AM | PBM | AM | |
Subjects n | 9 | 14 | 18 | |||
CD36 | 1528±237## | 13±4 | 1713±387## | 21±7 | 1695±188## | 13±3 |
CD51 | 23±8 | 18±3 | 26±13 | 22±3 | 16±6 | 18±3 |
CD61 | 89±12## | 8±2 | 231±59## | 16±3 | 119±31## | 10±2 |
CD14 | 474±21## | 36±7 | 544±37## | 50±17 | 502±33## | 25±6 |
CD44 | 1286±41 | 1371±102 | 1151±59 | 1305±48 | 1165±42 | 1199±74 |
HLA-DR | 35±4 | 46±5 | 37±7 | 44±4 | 29±3 | 28±2** |
CD80 | 1.2±0.7## | 39±4 | 1±0.1## | 38±6 | 1±0.2## | 19±4** |
CD86 | 29±3## | 248±16 | 28±4## | 253±14 | 25±2## | 220±19 |
CD40 | 13±2## | 305±26 | 21±6## | 326±27 | 21±4## | 291±28 |
CD11b | 685±49## | 39±9 | 731±44## | 52±6 | 719±38## | 49±6 |
Data presented as mean±sem. COPD: chronic obstructive pulmonary disease; HLA: human leukocyte antigen. **: p<0.01 with respect to nonsmokers and smokers with normal lung function; ##: p<0.01 within groups (PBM versus AM).